A detailed history of Acadian Asset Management LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 23,116 shares of PACB stock, worth $37,216. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,116
Holding current value
$37,216
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$1.17 - $1.69 $27,045 - $39,066
23,116 New
23,116 $29,000
Q3 2020

Nov 09, 2020

SELL
$3.61 - $9.87 $464,332 - $1.27 Million
-128,624 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$2.65 - $4.03 $340,853 - $518,354
128,624 New
128,624 $444,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $362M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.